<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38994492</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Cognitive functioning in patients with neuro-PASC: the role of fatigue, mood, and hospitalization status.</ArticleTitle><Pagination><StartPage>1401796</StartPage><MedlinePgn>1401796</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1401796</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2024.1401796</ELocationID><Abstract><AbstractText>This study sought to characterize cognitive functioning in patients with neurological post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC) and investigate the association of subjective and objective functioning along with other relevant factors with prior hospitalization for COVID-19. Participants were 106 adult outpatients with Neuro-PASC referred for abbreviated neuropsychological assessment after scoring worse than one standard deviation below the mean on cognitive screening. Of these patients, 23 had been hospitalized and 83 had not been hospitalized for COVID-19. Subjective cognitive impairment was evaluated with the self-report cognition subscale from the Patient-Reported Outcome Measurement Information System. Objective cognitive performance was assessed using a composite score derived from multiple standardized cognitive measures. Other relevant factors, including fatigue and depression/mood symptoms, were assessed via the Patient-Reported Outcome Measurement Information System. Subjective cognitive impairment measures exceeded the minimal difficulties noted on objective tests and were associated with depression/mood symptoms as well as fatigue. However, fatigue independently explained the most variance (17.51%) in patients' subjective cognitive ratings. When adjusting for fatigue and time since onset of COVID-19 symptoms, neither objective nor subjective impairment were associated with prior hospitalization for COVID-19. Findings suggest that abbreviated neuropsychological assessment may not reveal objective difficulties beyond initial cognitive screening in patients with Neuro-PASC. However, subjective cognitive concerns may persist irrespective of hospitalization status, and are likely influenced by fatigue and depression/mood symptoms. The impact of concomitant management of fatigue and mood in patients with Neuro-PASC who report cognitive concerns deserve further study.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Cahan, Finley, Cotton, Orban, Jimenez, Weintraub, Sorets and Koralnik.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cahan</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Northwestern Medicine, Davee Department of Neurology, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Finley</LastName><ForeName>John-Christopher A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Northwestern Medicine, Department of Psychiatry and Behavioral Sciences, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotton</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Northwestern Medicine, Davee Department of Neurology, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northwestern Medicine, Department of Psychiatry and Behavioral Sciences, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Zachary S</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Millenia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weintraub</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Northwestern Medicine, Davee Department of Neurology, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Northwestern Medicine, Department of Psychiatry and Behavioral Sciences, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorets</LastName><ForeName>Tali</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>Igor J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Northwestern Medicine, Davee Department of Neurology, Chicago, IL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">cognitive</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection (PASC)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>4</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38994492</ArticleId><ArticleId IdType="pmc">PMC11236596</ArticleId><ArticleId IdType="doi">10.3389/fneur.2024.1401796</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Center for Health Statistics  (2023). Long COVID. U.S. Census Bureau, household pulse survey. Available at: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (Accessed June 1, 2024).</Citation></Reference><Reference><Citation>Bailey J, Lavelle B, Miller J, Jimenez M, Lim PH, Orban ZS, et al. . Multidisciplinary Center Care for Long COVID syndrome&#x2013;a retrospective cohort study. Am J Med. (2023). doi: 10.1016/j.amjmed.2023.05.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.05.002</ArticleId><ArticleId IdType="pmc">PMC10200714</ArticleId><ArticleId IdType="pubmed">37220832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushwaha S, Seth V, Bapat P, Chaturvedi M, Gupta R. Neurological associations of COVID-19&#x2014;do we know enough: a tertiary care hospital-based study. Front Neurol. (2020) 11:588879. doi: 10.3389/fneur.2020.588879, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.588879</ArticleId><ArticleId IdType="pmc">PMC7732434</ArticleId><ArticleId IdType="pubmed">33329335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonner-Jackson A, Vangal R, Li Y, Thompson N, Chakrabarti S, Krishnan K. Factors associated with cognitive impairment in patients with persisting sequelae of Covid-19. Am J Med. (2024). doi: 10.1016/j.amjmed.2024.01.021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2024.01.021</ArticleId><ArticleId IdType="pubmed">38331138</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, et al. . The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. (2021) 21:44&#x2013;57. doi: 10.1007/s11910-021-01130-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Pavli A, Tsakris A. Post-COVID syndrome: an insight on its pathogenesis. Vaccine. (2021) 9:497. doi: 10.3390/vaccines9050497, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina Y, Enose-Akahata Y, Hammoud DA, Videckis AJ, Narpala SR, O'Connell SE, et al. . Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. (2023) 2:4. doi: 10.1212/NXI.0000000000000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000097</ArticleId><ArticleId IdType="pmc">PMC10162706</ArticleId><ArticleId IdType="pubmed">37147136</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo GS, Ali ST, Kang AK, Patel TR, Budhiraja S, Gaelen JI, et al. . Neurologic manifestations of long COVID differ based on acute COVID-19 severity. Ann Neurol. (2023) 94:146&#x2013;59. doi: 10.1002/ana.26649, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pmc">PMC10724021</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong IZ, Kolson DL, Schindler MK. Mechanisms, effects, and management of neurological complications of post-acute sequelae of Covid-19 (NC-PASC). Biomedicine. (2023) 11:377. doi: 10.3390/biomedicines11020377, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020377</ArticleId><ArticleId IdType="pmc">PMC9953707</ArticleId><ArticleId IdType="pubmed">36830913</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmoe W, Rao K, Gorter B, Kantor R. Neurocognitive impairment in post-COVID-19 condition in adults: narrative review of the current literature. Arch Clin Neuropsychol. (2024) 39:276&#x2013;89. doi: 10.1093/arclin/acae017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acae017</ArticleId><ArticleId IdType="pubmed">38520374</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. . Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. (2021) 4:e2130645. doi: 10.1001/JAMANETWORKOPEN.2021.30645, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANETWORKOPEN.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay CD, Costa AS, Vannorsdall TD, Aduen P, Vila-Castelar C, Burstein SM, et al. . Neuropsychological outcomes of COVID-19: a multicenter, cross-cultural study of patients referred for outpatient assessment. COVID. (2022) 2:1253&#x2013;64. doi: 10.3390/covid2090092</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2090092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, et al. . One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. (2022) 79:509&#x2013;17. doi: 10.1001/jamaneurol.2022.0461, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. . Cognitive deficits in people who have recovered from COVID-19. EClin Med. (2021) 39:101044. doi: 10.1016/j.eclinm.2021.101044, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R, et al. . Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom. J Neurol Sci. (2021) 420:117271. doi: 10.1016/j.jns.2020.117271, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117271</ArticleId><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Collantes ME, Espiritu AI, Sy MC, Anlacan VM, Jamora RD. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci. (2021) 48:66&#x2013;76. doi: 10.1017/cjn.2020.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.146</ArticleId><ArticleId IdType="pmc">PMC7492583</ArticleId><ArticleId IdType="pubmed">32665054</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. . Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. (2021) 4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C, Calabria M, Grunden N, Pons C, Arroyo JA, G&#xf3;mez-Anson B, et al. . Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. (2022) 12:e2508. doi: 10.1002/brb3.2508, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2508</ArticleId><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K, Miller AK, Reiter K, Bonner-Jackson A. Neurocognitive profiles in patients with persisting cognitive symptoms associated with COVID-19. Arch Clin Neuropsychol. (2022) 37:729&#x2013;37. doi: 10.1093/arclin/acac004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acac004</ArticleId><ArticleId IdType="pmc">PMC8903427</ArticleId><ArticleId IdType="pubmed">35136912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobrino-Rela&#xf1;o S, Balboa-Bandeira Y, Pe&#xf1;a J, Ibarretxe-Bilbao N, Zubiaurre-Elorza L, Ojeda N. Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis. Sci Rep. (2023) 13:10309. doi: 10.1038/s41598-023-37420-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-37420-6</ArticleId><ArticleId IdType="pmc">PMC10293265</ArticleId><ArticleId IdType="pubmed">37365191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolli GC, Alonso V, Yasuda CL, de Assump&#xe7;&#xe3;o D, Cachioni M, de Melo RC, et al. . Cognitive impairment in post-acute COVID-19 syndrome: a scoping review. Arq Neuropsiquiatr. (2023) 81:1053&#x2013;69. doi: 10.1055/s-0043-1777115</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1777115</ArticleId><ArticleId IdType="pmc">PMC10756850</ArticleId><ArticleId IdType="pubmed">38157873</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter L, Smyth H, Hoeritzauer I, Couturier A, Stone J, Carson AJ. What is brain fog? J Neurol Neurosurg Psychiatry. (2023) 94:321&#x2013;5. doi: 10.1136/jnnp-2022-329683</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329683</ArticleId><ArticleId IdType="pubmed">36600580</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. (2020) 12:69&#x2013;3. doi: 10.1186/s13195-020-00640-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Velichkovsky BB, Razvaliaeva AY, Khlebnikova AA, Manukyan PA, Kasatkin VN, Barmin AV. Systematic review and meta-analysis of clinically relevant executive functions tests performance after COVID-19. Behav Neurol. (2023) 2023:1094267. doi: 10.1155/2023/1094267, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/1094267</ArticleId><ArticleId IdType="pmc">PMC9935808</ArticleId><ArticleId IdType="pubmed">36815864</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannorsdall TD, Brigham E, Fawzy A, Raju S, Gorgone A, Pletnikova A, et al. . Cognitive dysfunction, psychiatric distress, and functional decline after COVID-19. J Acad Consult Liaison Psychiatry. (2022) 63:133&#x2013;43. doi: 10.1016/j.jaclp.2021.10.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2021.10.006</ArticleId><ArticleId IdType="pmc">PMC8591857</ArticleId><ArticleId IdType="pubmed">34793996</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W, et al. . Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. (2022) 18:1047&#x2013;66. doi: 10.1002/alz.12644, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, et al. . Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neuro-Oncol. (2021) 27:191&#x2013;5. doi: 10.1007/s13365-021-00954-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Basso MR, Naini SM, Porter J, Holker E, Waldron EJ, et al. . Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 1: cognitive functioning. Clin Neuropsychol. (2022) 36:806&#x2013;28. doi: 10.1080/13854046.2022.2030412, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2022.2030412</ArticleId><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley JC, Cladek A, Gonzalez C, Brook M. Perceived cognitive impairment is related to internalizing psychopathology but unrelated to objective cognitive performance among nongeriatric adults presenting for outpatient neuropsychological evaluation. Clin Neuropsychol. (2023) 38:644&#x2013;67. doi: 10.1080/13854046.2023.2241190, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2023.2241190</ArticleId><ArticleId IdType="pubmed">37518890</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. (2021) 8:130&#x2013;40. doi: 10.1016/S2215-0366(20)30462-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. (2022) 434:120162. doi: 10.1016/J.JNS.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlaja RE, Kauhanen LS, Ollila HS, Tuulio-Henriksson AS, Koskinen SK, Tiainen M, et al. . Associations of subjective and objective cognitive functioning after COVID-19: a six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health. (2023) 27:100587. doi: 10.1016/j.bbih.2023.100587, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100587</ArticleId><ArticleId IdType="pmc">PMC9812472</ArticleId><ArticleId IdType="pubmed">36624888</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Koralnik IJ, Liotta EM. Therapeutic approaches to the neurologic manifestations of COVID-19. Neurotherapeutics. (2022) 19:1435&#x2013;66. doi: 10.1007/s13311-022-01267-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01267-y</ArticleId><ArticleId IdType="pmc">PMC9302225</ArticleId><ArticleId IdType="pubmed">35861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al. . Cognition assessment using the NIH toolbox. Neurology. (2013) 80:S54&#x2013;64. doi: 10.1212/WNL.0B013E3182872DED, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0B013E3182872DED</ArticleId><ArticleId IdType="pmc">PMC3662346</ArticleId><ArticleId IdType="pubmed">23479546</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. . The patient reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. (2010) 63:1179&#x2013;94. doi: 10.1016/J.JCLINEPI.2010.04.011, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JCLINEPI.2010.04.011</ArticleId><ArticleId IdType="pmc">PMC2965562</ArticleId><ArticleId IdType="pubmed">20685078</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, et al. . Version 3 of the Alzheimer disease centers&#x2019; neuropsychological test battery in the uniform data set (UDS). Alzheimer Dis Assoc Disord. (2018) 32:10&#x2013;7. doi: 10.1097/WAD.0000000000000223, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000223</ArticleId><ArticleId IdType="pmc">PMC5821520</ArticleId><ArticleId IdType="pubmed">29240561</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilmette TJ, Sweet JJ, Hebben N, Koltai D, Mahone EM, Spiegler BJ, et al. . American Academy of clinical neuropsychology consensus conference statement on uniform labeling of performance test scores. Clin Neuropsychol. (2020) 34:437&#x2013;53. doi: 10.1080/13854046.2020.1722244, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1722244</ArticleId><ArticleId IdType="pubmed">32037942</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M, Yus M, G&#xf3;mez-Ruiz N, Polidura C, Gil-Mart&#xed;nez L, Delgado-Alonso C, et al. . Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. (2023) 146:2142&#x2013;52. doi: 10.1093/brain/awac384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac384</ArticleId><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. (2022) 604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S, et al. . Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. (2022) 50:1084&#x2013;9. doi: 10.1007/s00259-022-06013-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-06013-2</ArticleId><ArticleId IdType="pmc">PMC9628394</ArticleId><ArticleId IdType="pubmed">36322190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson BA, Visvabharathy L, Ali ST, Kang AK, Patel TR, Clark JR, et al. . Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. (2022) 9:e1151. doi: 10.1212/NXI.0000000000001151, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallanti S, Di Ponzio M, Gavazzi G, Gasic G, Besteher B, Heller C, et al. . From &#x2018;mental fog&#x2019; to post-acute COVID-19 syndrome's executive function alteration: implications for clinical approach. J Psychiatr Res. (2023) 167:10&#x2013;5. doi: 10.1016/j.jpsychires.2023.09.017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2023.09.017</ArticleId><ArticleId IdType="pubmed">37804756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrazik M, Millis S, Drane DL. The oral trail making test: effects of age and concurrent validity. Arch Clin Neuropsychol. (2010) 25:236&#x2013;43. doi: 10.1093/arclin/acq006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acq006</ArticleId><ArticleId IdType="pmc">PMC2858599</ArticleId><ArticleId IdType="pubmed">20197294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. . The characterisation of subjective cognitive decline. Lancet Neurol. (2020) 19:271&#x2013;8. doi: 10.1016/S1474-4422(19)30368-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30368-0</ArticleId><ArticleId IdType="pmc">PMC7062546</ArticleId><ArticleId IdType="pubmed">31958406</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. (2021) 8:1073&#x2013;85. doi: 10.1002/acn3.51350, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugarman MA, Axelrod BN. Embedded measures of performance validity using verbal fluency tests in a clinical sample. Appl Neuropsychol Adult. (2015) 22:141&#x2013;6. doi: 10.1080/23279095.2013.873439, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2013.873439</ArticleId><ArticleId IdType="pubmed">25153155</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley JCA, Brooks JM, Nili AN, Oh A, VanLandingham HB, Ovsiew GP, et al. . Multivariate examination of embedded indicators of performance validity for ADHD evaluations: a targeted approach. Appl Neuropsychol Adult. (2023):1&#x2013;14. doi: 10.1080/23279095.2023.2256440</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2023.2256440</ArticleId><ArticleId IdType="pubmed">37703401</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley JCA, Rodriguez VJ, Cerny BM, Chang F, Brooks JM, Ovsiew GP, et al. . Comparing embedded performance validity indicators within the WAIS-IV letter-number sequencing subtest to reliable digit span among adults referred for evaluation of attention-deficit/hyperactivity disorder. Clin Neuropsychol. (2024):1&#x2013;20. doi: 10.1080/13854046.2024.2315738, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2024.2315738</ArticleId><ArticleId IdType="pubmed">38351710</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>